Southern Illinois Associates
Community-based psychiatric practice (est. 2004) providing medication management and advanced evidence-based treatments for adults 18+. Services emphasize immediate access (walk-in clinic), specialized management of treatment-resistant conditions, neuromodulation (Deep TMS and accelerated protocols), ketamine- and esketamine-based therapies, cognitive assessment, caregiver support for dementia, and digital tools for monitoring and engagement.
Industries
Nr. of Employees
small (1-50)
Southern Illinois Associates
Products
Digital mental health app suite
Mobile and web applications for mood tracking, guided meditation, journaling, CBT-based thought restructuring, adaptive cognitive training and a centralized patient dashboard for clinicians.
HIPAA-compliant treatment pathway assessment (web)
Web-based, encrypted assessment tool that evaluates treatment history and contraindications to recommend evidence-based options for treatment-resistant depression.
Digital mental health app suite
Mobile and web applications for mood tracking, guided meditation, journaling, CBT-based thought restructuring, adaptive cognitive training and a centralized patient dashboard for clinicians.
HIPAA-compliant treatment pathway assessment (web)
Web-based, encrypted assessment tool that evaluates treatment history and contraindications to recommend evidence-based options for treatment-resistant depression.
Services
Outpatient Deep TMS for depression, OCD and smoking cessation with individualized treatment plans and trained technicians.
High-frequency, accelerated iTBS protocol delivering multiple sessions per day over 5 days for rapid symptom relief in treatment-resistant depression (off‑label, self-pay option available).
In-clinic administration of intranasal esketamine with induction and maintenance schedules, mandatory post‑dose observation and insurance coordination.
Medically supervised IM ketamine treatments with weight‑based dosing, pre‑screening, continuous monitoring and integration support; currently offered as self‑pay for many indications.
Cognitive screening using validated computerized tests, early detection of mild cognitive impairment, caregiver education, behavior management training and advance care planning guidance.
Comprehensive management including psychiatric evaluation, long‑acting injectable antipsychotics, psychotherapy referrals, family education and crisis planning.
Outpatient Deep TMS for depression, OCD and smoking cessation with individualized treatment plans and trained technicians.
High-frequency, accelerated iTBS protocol delivering multiple sessions per day over 5 days for rapid symptom relief in treatment-resistant depression (off‑label, self-pay option available).
In-clinic administration of intranasal esketamine with induction and maintenance schedules, mandatory post‑dose observation and insurance coordination.
Medically supervised IM ketamine treatments with weight‑based dosing, pre‑screening, continuous monitoring and integration support; currently offered as self‑pay for many indications.
Cognitive screening using validated computerized tests, early detection of mild cognitive impairment, caregiver education, behavior management training and advance care planning guidance.
Comprehensive management including psychiatric evaluation, long‑acting injectable antipsychotics, psychotherapy referrals, family education and crisis planning.
Expertise Areas
- Treatment‑resistant depression management
- Neuromodulation (Deep TMS and accelerated TMS protocols)
- Ketamine-based therapies (intramuscular) and intranasal esketamine
- Psychosis and long‑acting injectable antipsychotic management
Key Technologies
- Deep transcranial magnetic stimulation (Deep TMS, H‑coil systems)
- Intermittent theta‑burst stimulation (iTBS)
- Accelerated high‑dose TMS protocols (SAINT‑derived)
- Intramuscular ketamine administration
News & Updates
Clinical team guidance on mental health awareness, stigma reduction, and evidence-based self-care strategies.
Overview of transcranial magnetic stimulation, mechanisms, clinical outcomes and patient experience for TRD.
Discussion of evolving clinical research and applications of psychedelic-assisted approaches in mental health.
Providing psychiatric services in Madison County and the Metro East region since 2004.
Practice-reported patient volume (1,184+ patients served on assessment page).
Clinical team guidance on mental health awareness, stigma reduction, and evidence-based self-care strategies.
Overview of transcranial magnetic stimulation, mechanisms, clinical outcomes and patient experience for TRD.
Discussion of evolving clinical research and applications of psychedelic-assisted approaches in mental health.
Providing psychiatric services in Madison County and the Metro East region since 2004.
Practice-reported patient volume (1,184+ patients served on assessment page).